Authors: LEES AJ ABBOTT R BANERJI N BARRIE M BODDIE H BRADBURY P CLARKE C CLIFFORDJONES R CORSTON R CRITCHLEY E CRITCHLEY P CULL R DICK J DRAPER I ELLIS C FINDLEY L FOWLER T GALE A GARDNERTHORPE C GIBB W GIBSON JD GIBSON JM GODWINAUSTEN R GREENWOOD R HARDIE R HARLEY D HAWKES C HAWKINS S HILDICKSMITH M HUGHES R ILLIS L JESTICO J KAFETZ K KENNARD C KNIGHT R KOCEN R LEIGH N LOIZOU L LENTON R MACMAHON D MARSDEN CD MICHAEL W MITCHELL J MONRO P MORAN J MORGAN B MURDOCH P MUTCH W OVERSTALL P PARK D PARKES JD PENTLAND B PERKINS D PONSFORD R QUINN N RAWSON M REES J RIDDOCH D SCHON F SCHAPIRA A SHEPHERD D STERN G SUMMERS B TURNBULL C TURNER A VAKIL S WARD C WHITELEY A WILLIAMS A

Citation: Aj. Lees et al., COMPARISONS OF THERAPEUTIC EFFECTS OF LEVODOPA, LEVODOPA AND SELEGILINE, AND BROMOCRIPTINE IN PATIENTS WITH EARLY, MILD PARKINSONS-DISEASE - 3-YEAR INTERIM-REPORT, BMJ. British medical journal, 307(6902), 1993, pp. 469-472